Last week, drugmaker Moderna shipped the first batch of its rapidly developed coronavirus vaccine to researchers at the National Institute of Allergy and Infectious Diseases. The NIAID will start the first human tests on the experimental shot that may suppress the epidemic bug, and initial results may be available by July or August.
Moderna's coronavirus vaccine set for human testing
Sign up for AIChE SmartBrief
News for chemical engineers
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.